NCI Recognizes Dr. Melanie Thomas with New Team Leadership Award
Dr. Melanie Thomas of Hollings Cancer Center is one of eleven investigators in the nation chosen by the National Cancer Institute to receive a Cancer Clinical Investigator Team Leadership Award.
The award provides recognition and funding for those who lead cancer research programs at academic cancer centers. Recipients are selected on the basis of their exceptional contributions to the advancement of effective new therapies through their collaborative team science approach within NCI-funded clinical trials. They are provided with partial salary support for two years for their leadership roles in clinical trials at NCI-designated cancer centers.
The purpose of the award is to offer support and provide academic recognition to investigators who promote collaborative team science. “We are truly excited to be able to recognize these key clinical investigators without whom we couldn’t conduct clinical trials,” said Dr. Sheila Prindiville, director of NCI’s Coordinating Center for Clinical Trials, the office that oversees implementation of the CTWG’s recommendations. “These recipients have exceptional leadership skills in cancer clinical trial activities and have demonstrated a commitment to conducting cancer clinical trials that promise to advance care for patients.” The award will grant Dr. Thomas $50,000 in each of the next 2 years.
Dr. Thomas holds the Grace E. DeWolf Endowed Chair in Medical Oncology. She is Associate Professor of Medicine specializing in clinical and research studies in cancer of the pancreas, gallbladder, liver, colon and rectum. Dr. Thomas received her MD from Boston University School of Medicine, trained at Beth Israel Deaconess Medical Center, and completed fellowship training in Hematology-Oncology at University of Texas M.D. Anderson.